Cidara Therapeutics, a US biotech leveraging its Cloudbreak platform for next‑generation antivirals, saw its stock more than ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current ...

Shares of San Diego-based Cidara Therapeutics Inc. (NASDAQ:CDTX) were trading at $40.41, up $19.39, or 92%, on positive top-line results from its randomized, double-blind, placebo-controlled phase IIb ...

Single doses of 450mg, 300mg and 150mg of CD388 conferred 76%, 61% and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo End of Phase 2 meeting request has ...

Current nomenclature for influenza viruses (WHO 1980 ... the 1900s); The subtype [16 possible hemagglutinin and 9 possible neuraminidase subtypes]. Thus, a type A virus isolated in 1995 in ...

Neuraminidase inhibitors are a vital treatment option for patients with influenza." Roche concluded by claiming that other studies, including trials and real-world data have shown the drug's ...

Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian ...

The antiviral baloxavir significantly reduced household transmission of influenza compared with placebo. The drug showed consistent effects across age groups, virus types, and countries ...

CSIR-Centre for Cellular & Molecular Biology, Uppal Road, Hyderabad 500007 (AP), India. The authors are grateful to the Council of Scientific and Industrial Research (CSIR-CCMB), India, for ...

Its purpose being to support pandemic preparedness for influenza and other infectious disease threats, this is the first award from BARDA – part of the US Department of Health and Human Services ...

A person may still be able to get the flu shot when sick with mild illnesses, such as colds and sinus infections. However, a doctor may recommend delaying the shot if the person has severe ...

The current predominant strain is called “Influenza A H3.” “We are seeing an enormous amount of flu. Maybe a third of the patients I have here have flu,” said Dr. Nick Moore, an emergency ...